Table 11 Prevalence of sleep disorders (SDs) among psoriatic patients in different studies.
Study | Year | Total number of patients | Prevalence of SDs (%) | Method for evaluating SDs |
|---|---|---|---|---|
Sharma et al.13 | 2001 | 30 | 56.7 | GHQ-H |
Delfino et al.14 | 2008 | 40 | 55 | Interview |
Stiens et al.15 | 2008 | 135 | 34 | Interview |
Callis Duffin et al.16 | 2009 | 420 | 49.5 | Interview |
Hu et al.17 | 2010 | 100 | 60 | Interview |
Tsai et al.18 | 2011 | 51,800 | 0.05 | Interview |
Ljosaa et al.19 | 2012 | 139 | 62.6 | GSDS |
Shutty et al.20 | 2013 | 35 | 77.1 | PSQI |
Nyunt et al.21 | 2013 | 223 | 40.9 | Interview |
Sanchez-Carazo et al.22 | 2014 | 1022 | 12.2 | Interview |
Chiu et al.23 | 2016 | 99,628 | 2.2 | Interview |
Melikoglu 24 | 2017 | 58 | 60.3 | PSQI |
Henry et al.25 | 2017 | 186 | 76.8 | PSQI |
Wong et al.26 | 2017 | 62 | 69.3 | PSQI |
Jensen et al.27 | 2018 | 179 | 53.6 | PSQI |
Krajewska-Włodarczyk et al.28 | 2018 | 52 | 57.7 | PSQI |
Saçmacı and Gurel 12 | 2019 | 60 | 90 | PSQI |
Duvetorp et al.29 | 2019 | 911 | 16.3 | Interview |
Hawro et al.30 | 2020 | 104 | 39.4 | DLQI |
Luca et al.31 | 2020 | 83 | 83.9 | PSQI |
Nowowiejska et al.32 | 2021 | 60 | 78.3 | PSQI |
Jaworecka et al.33 | 2022 | 295 | 39.3 | DLQI |
Sahin et al.34 | 2022 | 334 | 59 | PSQI |
Khalaf et al.35 | 2023 | 100 | 38 | PSQI |
